Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media

Br J Cancer. 1986 Oct;54(4):587-94. doi: 10.1038/bjc.1986.213.

Abstract

Lung tumours of non small cell pathology were cultured by clonogenic assay in several media. Culture was successful in spleen conditioned medium, but only 57% grew and low plating efficiencies (PE) meant that only 23% of the original number produced significant drug results. Comparison of rat erythrocyte lysate (REL) medium with serum free defined medium (HITES) and HITES + 10% FBS demonstrated clear enhancement of PE in REL although growth was 100% successful in all these media. Ninety-three percent of samples tested against drugs in REL produced significant results. A later comparison of REL with McCoy's 5A + rbc +/- hydrocortisone produced relatively poor culture success for these 3 media and equivocal growth patterns. Low PE was attributed to age of rats used for rbc. Vindesine and cis-platinum cytotoxicity in spleen conditioned medium were 61% and 15% sensitivity respectively. These do not concur with clinical experience but the figures for overt resistance, at 39% and 69%, correspond with expected non-responders to these regimes. Drug testing in REL produced figures correlating more closely with clinical performance at 45% sensitivity to platinum and 36% of patients sensitive to both drugs, but the vindesine sensitivity at 55% is again discrepant with performance of this drug as a single agent.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use
  • Colony-Forming Units Assay*
  • Culture Media*
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology*
  • Tumor Stem Cell Assay*
  • Vindesine / pharmacology
  • Vindesine / therapeutic use

Substances

  • Culture Media
  • Cisplatin
  • Vindesine